Our results provide evidence that further supports the role VEGFB, VEGFD, FLT1, FLT4, and NRP1 play inside and outside of the classic VEGF signaling axis in AD, with support for both an endothelial and microglial signaling cascade that could underlie these well‐established associations. Here, FLT1 is linked to Alzheimer disease.